Treatment for head and neck cancer is constantly evolving. Once treated mainly with surgery, head and neck cancer treatment now involves cooperative, multidisciplinary teams to achieve the best possible outcome. Our treatment team includes surgeons, radiation oncologists, medical oncologists, pathologists, radiologists, speech therapists, rehabilitative specialists, as well as ancillary support services. Our goal is to treat patients using the most effective tools available in the world.
As a surgeon actively involved in the care of patients with head and neck cancer, my role is to serve as leader of the treatment team. I have extensive experience in surgery and an in-depth understanding of each of the disciplines involved in the treatment of head and neck cancer. My philosophy to treat the whole patient, not just the cancer, serves as the basis for our team approach.
I have been involved with clinical care at Memorial Sloan Kettering for more than a decade and have learned during this time that even though our current treatment approaches are effective, they do not work for every patient. My desire to improve patient cure rates and quality of life has led me to study cancer genetics to gain a better understanding of head and neck cancers. I obtained a PhD to supplement my clinical knowledge, and I now am actively involved in clinical and laboratory research aimed at improving the treatment of patients with cancer. Our research has helped to establish treatment approaches that serve as cornerstones for modern management of head and neck cancers.
Given the effectiveness of our treatment approaches and research efforts, I was appointed Director of the Laboratory of Epithelial Cancer Biology, and I have been asked to share my expertise at numerous national and international meetings. I have authored more than 100 articles and 20 book chapters related to head and neck cancers. In addition, the American Joint Committee on Cancer has asked me to help develop a new staging system for head and neck cancers, which will serve as the basis for state-of-the-art therapeutic decision making.
My expertise extends to all head and neck cancers, with a particular focus on cancers of the mouth (tongue, floor of mouth, and buccal mucosa), skull base, and salivary and thyroid glands, as well as melanomas and skin cancers of the head and neck region. Once my team takes on the responsibility of your treatment, we will aggressively pursue all avenues to achieve a cure.
- Clinical Expertise: Head and Neck Surgery/Oncology
- Languages Spoken: English
- Education: MD, SUNY Downstate College of Medicine; PhD, Netherlands Cancer Institute/University of Amsterdam
- Residencies: SUNY Downstate Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Otolaryngology-Head and Neck Surgery
Selected Books and Book Chapters
“Quality of life and rehabilitation.” Singh B. In: Cancer of the Head and Neck — American Cancer Society Atlas of Clinical Oncology. Shah JP, Patel SG, eds. London: BC Decker; 2001.
“Skin cancers of the head and neck.” Singh B. In: Cancer of the Head and Neck — American Cancer Society Atlas of Clinical Oncology. Shah JP, Patel SG, eds. London: BC Decker; 2001.
“Cervical lymph nodes and unknown primary.” Singh B. In: The Practice of General Surgery. Bland KI, Shah JP, eds. Philadelphia: WB Saunders; 2002: 279-297.
“Surgical approached to the oral cavity.” Carew J, Singh B, Shah JP. In: Oral Cancer. Shah JP, Batsakis JG, Johnson NW, eds. London: Martin Dunitz; 2003: 249-296.
“Basic science of head and neck cancer.” Singh B. In: Head and Neck Surgery and Oncology. 3rd ed. Shah JP, Patel S, eds. St. Louis: Mosby; 2003: 679-694.
“Quality of life and functional outcome in head and neck cancer.” Singh B. In: Head and Neck Surgery and Oncology. 3rd ed. Shah JP, Patel S, eds. St. Louis: Mosby; 2003: 673-678.
“Thyroid cancer: oncogenes and tumor markers.” Patel KN, Singh B. In: Practical Manual of Thyroid and Parathyroid Disease. Arora A, Tuttle RM, Tolley N, eds. Hoboken, NJ: Wiley-Blackwell; 2010.
“What is the new concept of functional modified neck dissection?” Singh B. In: Pearls and Pitfalls in Head and Neck Surgery. Practical Tips to Minimize Complications. Cernea CR, et al., eds. Basel, Switzerland: Karger; 2008: 58-9.
“Nonepidermoid cancers of the head and neck.” Castro J, Kummer BR, Singh B. In: Plastic Surgery: Indications and Practice. Guyuron B, Eriksson E, Persing JA, Chung K, Disa J, Gosain A, Rubin JP, Kinney B, eds. Philadelphia: WB Saunders; 2009.
Head and Neck Surgery and Oncology. 4th ed. Shah JP, Patel S, Singh B, eds. St. Louis: Mosby; 2012.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more